Senior insider sale
EVP, Reg. Strategy, Clinical at DEXCOM INC — senior position signals high conviction
$1.31M
9.90K shares
What this filing means
BALO ANDREW K plans to sell 9.90K shares of DEXCOM INC valued at approximately $1.31M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/14/2023ACC: 0001950047-23-002347
Officer· EVP, Reg. Strategy, Clinical
Since Jul 2018
9.90K
Shares to sell
$1.31M
Approx. market value
4.96K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
3/8/2021
4.96KTotal acquired4.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/8/2021 | Restricted Stock Not Applicable | 4.96K | — |
| Total | 4.96K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.94K
Market value
$642.2K
6/15/2023
Planned — Approximate Date
NASDPlanned
Units to sell
4.96K
Market value
$669.1K
7/14/2023
Total
Units
9.90K
Value
$1.31M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/15/2023 | 4.94K | $642.2K | — | Completed |
| Planned — Approximate Date | ||||
7/14/2023 | 4.96K | $669.1K | NASD | Planned |
| Total | 9.90K | $1.31M | ||